149 results on '"Galati, Giuseppe"'
Search Results
2. Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
3. FREQUENT EXTRASYSTOLIC ARRHYTHMIA: PERCEIVED PSYCHOLOGICAL WELL-BEING EVALUATION.
4. QUALITY OF LIFE EVALUATION IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION.
5. Motor Vehicle Challenge 2023: The Winning Multi-physical Energy Management Algorithm
6. Hypotension and optimization of heart failure therapy after a recent hospitalization for heart failure: When the going gets tough, the tough get going
7. Novel “Ex-PRO” score for the cardiovascular complications prediction in extrasystolic arrhythmia
8. Pathophysiology and management of recreational drug-related acute coronary syndrome: ANMCO position statement
9. Fault-Tolerant Analysis of Kalman Filter Sensor Fusion for Sensorless Control of a Multiphase Machine
10. Abstract 12790: Classification of the Different Types of Hypertrophic Cardiomyopathy Responsible for Advanced Heart Failure: From Clinical, Morphofunctional Characteristics to Prognosis and Potential New Therapies
11. New approaches to reduce recurrent PCI: to angioplasty and beyond!
12. Modelling of a Rotating Signal Injection-Based Position Observer for Sensorless Synchronous Electric Drives
13. Carotid bifurcation stenosis: functional importance in physical exercises
14. Improved Sensorless Control of Multiphase Synchronous Reluctance Machine Under Position Sensor Fault
15. PREMATURE VENTRICULAR CONTRACTIONS AS AN ADDITIONAL RISK FACTOR FOR THE ARTERIAL THROMBOEMBOLISM
16. Improved Sensorless Control of Multiphase Synchronous Reluctance Machine Under Position Sensor Fault
17. Hypotension and optimization of heart failure therapy after a recent hospitalization for heart failure: When the going gets tough, the tough get going
18. Investigation on the Self-Sensing Capability of a Dual Three-Phase Synchronous Reluctance Machine
19. PREMATURE VENTRICULAR CONTRACTIONS: THE NOVEL INDEPENDENT RISK FACTOR OF CRYPTOGENIC STROKE
20. Functional differentiation of cytotoxic cancer drugs and targeted cancer therapeutics
21. The operation of carotid endarterectomy: is it an effective method of treatment of arterial hypertension?
22. MODELING OF INTRA-ARTERIAL CIRCULATION: APPLICATION IN EXPERIMENTAL CARDIOLOGY
23. The operation of carotid endarterectomy: is it an effective method of treatment of arterial hypertension?
24. APPLICATION OF SF-36 HEALTH STATUS SURVEY IN PATIENTS WITH ARTERIAL HYPERTENSION.
25. ISCHEMIC STROKE IN PATIENTS WITH EXTRASYSTOLIC ARRHYTHMIA: CASE SERIES.
26. PERCEIVED PSYCHOLOGICAL WELL-BEING IN PATIENTS WITH HEMODYNAMICALLY INSIGNIFICANT CAROTID ARTERIES STENOSIS.
27. Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis.
28. Atrial fibrillation as a new independent risk factor for thromboembolic events: hemodynamics and vascular consequence of long ventricular pauses.
29. Proprotein convertase subtilisin kexin type 9 and main artery atherosclerosis in patients with arterial hypertension.
30. Extrasystolic arrhythmia: is it an additional risk factor of cryptogenic stroke?
31. Proprotein convertase subtilisin kexin type 9 and main arteries atherosclerosis in patients with arterial hypertension
32. Extrasystolic arrhythmia: is it an additional risk factor of atherosclerosis?
33. Atrial fibrillation: a new independent risk factor for thromboembolic events - hemodynamics and vascular consequence of long ventricular pauses
34. Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis
35. 388 Haemodynamic arterial changes in heart failure: a proposed new paradigm of heart and vessels failure. The Copernican revolution?
36. Women and Diabetes: Preventing Heart Disease in a New Era of Therapies
37. Extrasystolic arrhythmia – an unaccounted risk factor of atherosclerosis development in main arteries?
38. Hemodynamic arterial changes in heart failure: a proposed new paradigm of "Heart and Vessels Failure (HVF)"
39. LV Strain Superiority Over LVEF in HFmrEF: Is the Job Done After David’s Victory Over Goliath?
40. Myocardial amyloid infiltration: a less than expected homogeneous process
41. The difficult diagnosis of isolated cardiac sarcoidosis: usefulness of an integrated MRI and PET approach
42. Hemodynamic arterial changes in heart failure: a proposed new paradigm of “heart and vessels failure”.
43. Modeling of restenosis of main arteries after the intravascular stenting interventions
44. Extrasystolic arrhythmia: is it an additional risk factor of atherosclerosis?
45. CRYPTOGENIC STROKE IN THE CONTEXT OF PANDEMIC-RELATED STRESS: THE ROLE OF ARTERIAL HEMODYNAMICS.
46. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins
47. Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
48. Pathophysiology and management of recreational drug-related acute coronary syndrome: ANMCO position statement
49. The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure management
50. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.